Literature DB >> 21678433

Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.

Adriana Santarém Ferreira1, Ludimila Paula Vaz Cardoso, Mariane Martins de Araújo Stefani.   

Abstract

Few reports have described the molecular characteristics of the AIDS epidemic within the interior regions of Brazil, a country of continental dimensions. To help fill this gap, the prevalence of transmitted antiretroviral drug resistance and human immunodeficiency virus type 1 (HIV-1) diversity in Mato Grosso State, central western Brazil are reported. Drug-naïve patients (n = 105) were recruited at a reference center in Cuiabá/Mato Grosso State located across the border with Bolivia and considered a southern gate to the Amazon forest. For 92 HIV-1 isolates, the protease and partial reverse transcriptase fragments were amplified by nested-PCR and sequenced. Drug resistance was analyzed by the Calibrated Population Resistance tool and the International AIDS Society-USA database. HIV-1 subtypes were determined by REGA and phylogenetic analyses. Recombinant viruses were analyzed by SIMPLOT. Drug resistance mutations were observed in 5.4%: nucleoside reverse transcriptase inhibitor mutations M41L (n = 1), D67N (n = 1), and K219E (n = 1), the non-nucleoside reverse transcriptase inhibitor mutation K103N (n = 1) and the protease inhibitor mutation L90M (n = 1). Around 20% of the isolates were recombinants: different patterns of B/F1 mosaics (n = 11), four B/C, one F1/C/B, one F1/C, and one D/F1. Subtype B(PR) B(RT) represented 71.7%, 5.4% were of subtype C(PR) C(RT) and 3.3% were of subtype F1(PR) F1(RT) . A moderate prevalence of transmitted resistance and the co-circulation of subtypes B, F1, C, different recombinants, including the first report of subtype D, were found in Mato Grosso State, far from the epicenter of the epidemic. These results highlight the importance of monitoring transmitted drug resistance and HIV-1 genetic diversity in the interior regions of Brazil.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21678433     DOI: 10.1002/jmv.22128

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Contribution of Epidemiological Predictors in Unraveling the Phylogeographic History of HIV-1 Subtype C in Brazil.

Authors:  Tiago Gräf; Bram Vrancken; Dennis Maletich Junqueira; Rúbia Marília de Medeiros; Marc A Suchard; Philippe Lemey; Sabrina Esteves de Matos Almeida; Aguinaldo Roberto Pinto
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

2.  Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil.

Authors:  Rodrigo Pessôa; Jaqueline Tomoko Watanabe; Paula Calabria; Cecilia Salete Alencar; Paula Loureiro; Maria Esther Lopes; Anna Barbara Proetti; Alvina Clara Félix; Ester C Sabino; Michael P Busch; Sabri S Sanabani
Journal:  Transfusion       Date:  2014-11-21       Impact factor: 3.157

3.  Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhão State, northeast Brazil.

Authors:  Maria Edileuza Soares Moura; Mônica Nogueira da Guarda Reis; Yanna Andressa Ramos Lima; Kelsen Dantas Eulálio; Ludimila Paula Vaz Cardoso; Mariane Martins de Araújo Stefani
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-20       Impact factor: 2.205

Review 4.  Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.

Authors:  Santiago Avila-Rios; Omar Sued; Soo-Yon Rhee; Robert W Shafer; Gustavo Reyes-Teran; Giovanni Ravasi
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

5.  Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.

Authors:  Brunna M Alves; Juliana D Siqueira; Marianne M Garrido; Ornella M Botelho; Isabel M Prellwitz; Sayonara R Ribeiro; Esmeralda A Soares; Marcelo A Soares
Journal:  Viruses       Date:  2017-12-19       Impact factor: 5.048

6.  Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions.

Authors:  Mônica Nogueira da Guarda Reis; Gonzalo Bello; Monick Lindenmeyer Guimarães; Mariane Martins Araújo Stefani
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

Review 7.  The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.

Authors:  Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

8.  Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in Brazil.

Authors:  Edson Delatorre; José C Couto-Fernandez; Monick Lindenmayer Guimarães; Ludimila Paula Vaz Cardoso; Keila Correia de Alcantara; Mariane Martins de Araújo Stefani; Hector Romero; Caio C M Freire; Atila Iamarino; Paolo M de A Zanotto; Mariza G Morgado; Gonzalo Bello
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

9.  HIV-1 diversity and drug resistance mutations among people seeking HIV diagnosis in voluntary counseling and testing sites in Rio de Janeiro, Brazil.

Authors:  Carlos A Velasco-de-Castro; Beatriz Grinsztejn; Valdiléa G Veloso; Francisco I Bastos; José H Pilotto; Nilo Fernandes; Mariza G Morgado
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

10.  Epidemiological and clinical profile of HIV-infected patients from Southwestern Goias State, Brazil.

Authors:  Regyane Ferreira Guimarães Dias; Luciana Oliveira Bento; Camila Tavares; Hélio Ranes Filho; Melisia Adelaide Cesário da Silva; Luciene Carneiro Moraes; Ana Amélia Freitas-Vilela; Marcos Lázaro Moreli; Ludimila Paula Vaz Cardoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-07-19       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.